Method for detecting NAFLD or NASH or predicting risk, diagnostic kit for detecting NAFLD or NASH, method for determining the progress of liver fibrosis in a subject, and diagnosis for determining the progress of liver fibrosis in a subject Medicine kit

摘要

[PROBLEMS] To provide a new NAFLD and NASH diagnostic method that can be implemented more simply and does not place a burden on patients and medical staff, and subjects that may suffer from NAFLD and NASH It is an object of the present invention to provide a new method for determining the degree of liver fibrosis that does not place a burden on patients and medical workers. A total amount of carnitine, which is the total amount of free carnitine and total amount of acylcarnitine in a biological sample, is measured, and the total amount of acylcarnitine is measured by subtracting the amount of free carnitine from the total amount of carnitine. By comparing the measurement result with the reference value, early diagnosis of NAFLD and NASH and determination of the degree of liver fibrosis can be made. [Selection figure] None